Abstract:Background Delirium is the most common central nervous system complication after surgery. Detection of phosphorylated neurofilament heavy subunit in the serum reflects axonal damage within the central cervous system and is associated with the severity of postoperative delirium. Neuron-specific enolase and S100 calcium-binding protein β have been identified as possible serum biomarkers of postoperative delirium. This study examined the association of the levels of these markers with incidence of postoperative delirium and detection of phosphorylated neurofilament heavy subunit. Methods This study represents a post hoc analysis of 117 patients who participated in a prospective observational study of postoperative delirium in patients undergoing cancer surgery. Patients were clinically assessed for development of postoperative delirium within the first five days of surgery. Serum levels of phosphorylated neurofilament heavy subunit, neuron-specific enolase, and S100 calcium-binding protein β levels were measured on postoperative day 3. Results Forty-one patients (35%) were clinically diagnosed with postoperative delirium. Neuron-specific enolase level ( P < 0.0001) and the proportion of patients positive for phosphorylated neurofilament heavy subunit ( P < 0.0001) were significantly higher in the group of patients with postoperative delirium. Neuron-specific enolase level discriminated between patients with and without clinically diagnosed postoperative delirium with significantly high accuracy (area under the curve [AUC], 0.87; 95% confidence interval [CI], 0.79–0.95; P < 0.0001). Neuron-specific enolase level was associated with incidence of postoperative delirium independently of age (adjusted odds ratio, 8.291; 95% Cl, 3.506−33.286; P < 0.0001). The AUC for the serum neuron-specific enolase level in detecting phosphorylated neurofilament heavy subunit was significant (AUC, 0.78; 95% CI, 0.66–0.90; P < 0.0001). Conclusion Elevated serum neuron-specific enolase was associated with postoperative delirium independent of age as well as detection of phosphorylated neurofilament heavy subunit in serum. Serum neuron-specific enolase and phosphorylated neurofilament heavy subunit might be useful as biomarkers of postoperative delirium. Trial registration University Medical Information Network (UMIN) trial ID: UMIN000010329 ; https://clinicaltrials.gov/ .

Serum endocan and preoperative systemic inflammatory markers in patients with epilepsy

Lesional Intractable Epileptic Spasms in Children: Electroclinical Localization and Postoperative Outcomes

Serum SIRT3 levels in epilepsy patients and its association with clinical outcomes and severity: A prospective observational study

Inflammatory and neurotrophic factor plasma levels are related to epilepsy independently of etiology

Concentration of IL-1β, IL-7, IL-12, IL-17, CX3CL1, ITAC and relation with the seizure severity and sudden unexpected death in epilepsy patient

Correlation between inflammatory markers over time and disease severity in status epilepticus: a preliminary study

Evaluation of systemic inflammation in seizure phenotypes following meningioma resection

Elevated Serum Matrix Metalloproteinase-9, Interleukin-6, Hypersensitive C-Reactive Protein, and Homocysteine Levels in Patients with Epilepsy.

The role of biomarkers in drug-resistant trigeminal neuralgia: a prospective study in patients submitted to surgical treatment

Clinical Characteristics and Prognostic Significance of Subclinical Seizures in Focal Epilepsy: A Retrospective Study

Alteration of Plasma Cytokines in Patients with Active Epilepsy

Elevated plasma neurofilament light and glial fibrillary acidic protein in epilepsy versus nonepileptic seizures and nonepileptic disorders

Inflammation and iron metabolism in adult patients with epilepsy: Does a link exist?

Elevated neuron-specific enolase level is associated with postoperative delirium and detection of phosphorylated neurofilament heavy subunit: A prospective observational study

Predictors of Outcome in the Surgical Treatment for Epilepsy.

Factors Affecting Seizure Outcome after Epilepsy Surgery: an Observational Series

Identification of serum biomarkers for evaluating seizure outcome after resective epilepsy surgery

Molecular biomarkers in drug-resistant epilepsy: Facts & possibilities

Systemic evidence of acute seizure-associated elevation in serum neuronal injury biomarker in patients with temporal lobe epilepsy

A Meta-Analysis of Neuron-Specific Enolase Levels in Cerebrospinal Fluid and Serum in Children with Epilepsy

Clinical Predictors of 2-Year Outcome of Resective Epilepsy Surgery in Adults with Refractory Epilepsy: a Cohort Study